Sub-totipotent Stem Cell Identification via Histone Methylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for examining the differentiation potential of stem cells are time-consuming and resource-intensive, and there is a lack of unified phenotypes and culture conditions for adult stem cells (ASCs), making it difficult to establish homogeneous cell lines for clinical applications, while existing methods for predicting differentiation potential are not accurate or efficient.
Innovation Solution
The development of sub-totipotent stem cells with epithelioid morphology and Flk1+ phenotype, induced using specific growth factors, and the use of histone methylation modification states of specific genes to predict differentiation potential through ChIP-Seq and ChIP-PCR techniques, allowing for quick and accurate determination of differentiation potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods are used to examine differentiation potential of stem cells, then comprehensive assessment can be obtained, but the process is time-consuming and resource-intensive
Solution Approach 1:
The patent applies preliminary action by establishing histone modification state profiles (H3K4me3 and H3K27me3) as predictive markers before actual differentiation occurs. By analyzing the epigenetic landscape in advance, the method predicts differentiation potential without requiring lengthy differentiation experiments, thus resolving the contradiction between comprehensive assessment accuracy and time consumption.
2Reliability
If adult stem cells are used for clinical applications, then ethical issues and tumorigenicity are avoided, but lack of unified phenotypes and culture conditions makes it difficult to establish homogeneous cell lines
Solution Approach 1:
The patent applies parameter changes by using histone modification states (epigenetic parameters) as standardized markers to define and identify sub-totipotent stem cells. By establishing specific H3K4me3 and H3K27me3 modification patterns as diagnostic criteria, the method creates unified identification parameters for adult stem cells, reducing the complexity of establishing homogeneous cell lines while maintaining safety advantages.
3Measurement precision
If existing methods are used to predict differentiation potential, then some prediction capability is achieved, but accuracy and efficiency are insufficient
Solution Approach 1:
The patent applies the extraction principle by isolating and focusing on specific histone modification markers (H3K4me3 and H3K27me3 states at key gene loci) that are most predictive of differentiation potential. By extracting these critical epigenetic features from the complex cellular landscape, the method achieves high prediction accuracy with efficient, targeted assays rather than comprehensive but time-consuming analyses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a method to obtain stem cells with controlled differentiation potential towards triploblastic lineages without tumorigenicity, offering ideal seed cells for clinical regeneration and repair, and enables the prediction of differentiation potential by analyzing histone methylation states, thereby streamlining the identification and evaluation of stem cell differentiation capabilities.
Implementation Method 1
Methylation of histone refers to methylation occurring at arginine or lysine residues at the N-terminal of H3 and H4 histones, which is mediated by histone methyltransferase. Methylation of lysine of histone has become an important regulatory mechanism of transcription and plays an important role in the formation of heterochromatin, inactivation of X chromosome, genomic imprinting, repair of DNA damage, and regulation of gene transcription
Implementation Method 2
All DNA samples binding to specific antibodies against the triple-methylated lysine of Histone H3 at position 4 and against the triple-methylated lysine of Histone H3 at position 27 are obtained from said stem cells with ChIP technique
Data Source
AI summary
Provided are a sub-totipotent stem cell product and epigenetic modification label thereof, a method for inducing the generation of the sub-totipotent stem cell product and identification for the epigenetic modification label of the differentiation potential of stem cells. Also provided is a use of histone modification states of sub-totipotent genes and/or differentiation related genes to predict the epigenetic modification label of the differentiation potentials of stem cells.